Corp Incyte serves as Executive at AGENUS INC, where they oversee executive responsibilities. Since joining the company, Corp Incyte has executed 7 insider transactions totaling $62.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 25, 2021 involved receiving (via award) 350,000 shares valued at $8.7M.
Corp Incyte currently holds 3,550,000 shares of AGENUS INC (AGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Corp Incyte has been a net buyer of AGEN stock. They have purchased $60.0M and sold $2.9M worth of shares.
Corp Incyte's most recent insider trade was on Jan 25, 2021, when they sold 350,000 shares at $24.75 per share.
Get notified when new Form 4 filings are submitted
| $3.66 |
| Discretionary |
| Jun 16, 2020 | AGEN | $263.8K | Sale | 72,080 | $3.66 | Discretionary |
| Jun 15, 2020 | AGEN | $1.4M | Sale | 384,025 | $3.57 | Discretionary |
| Jun 12, 2020 | AGEN | $32.6K | Sale | 9,100 | $3.58 | Discretionary |
| Jun 11, 2020 | AGEN | $693.2K | Sale | 183,875 | $3.77 | Discretionary |
| Feb 14, 2017 | AGEN | $60.0M | Purchase | 10,000,000 | $6.00 | Discretionary |